Mechanisms of pain transmission and pharmacologic management

Abstract Background: Pain sensation involves multiple signaling and modulatory pathways, employing a variety of neurotransmitters and other mediators. Inhibitory and facilitatory mechanisms affect the perception of stimuli as painful or non-painful, and in addition may affect the perceived intensity of pain. Endogenous opioids are key mediators in the descending pain suppression pathways. Additionally, monoaminergic neurotransmitters such as norepinephrine, serotonin and dopamine positively or negatively modulate pain signaling, depending on receptor type and location. The various mediators involved in pain signaling provide potential targets for pharmacological interventions. Single analgesic therapies may be limited in their ability to comprehensively target these complex pain signaling pathways. Therapeutic approaches acting on multiple pain transmission pathways through different mechanisms of action provide an opportunity to maximize efficacy and tolerability in the treatment of pain. Scope: This article discusses the various physiologic processes involved in pain signaling and modulation, describes the mechanisms by which various classes of analgesic agents are believed to produce their clinical effects, and explores the potential benefits of a multiple-mechanism approach to analgesia. Published articles describing the physiologic processes involved in pain signaling and modulation and the mechanisms of analgesia for different drug classes were reviewed. MEDLINE searches were conducted to identify relevant studies published through August 2009 that evaluated the efficacy and tolerability of multiple-mechanism analgesic regimens. English language-only randomized controlled trials and meta-analyses of randomized controlled trials were considered. Findings/conclusion: Multiple neurotransmitters and other mediators are involved in the endogenous modulation of pain signaling, providing numerous opportunities for intervention with different classes of analgesics. Data from numerous clinical trials indicate that multiple-mechanism approaches to analgesia provide comparable or superior analgesic efficacy with lower doses of the individual agents and reduced incidence of side effects. These data support current guidelines which endorse multiple-mechanism strategies for both acute and chronic pain management.

[1]  T. Gan,et al.  Optimising Postoperative Pain Management in the Ambulatory Patient , 2012, Drugs.

[2]  J. Urquhart,et al.  [Compliance, concordance, adherence]. , 2010, Therapeutische Umschau. Revue therapeutique.

[3]  S. Daniels,et al.  A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study. , 2010, Clinical therapeutics.

[4]  H. Park,et al.  Pharmacologic Management of Chronic Pain , 2010, The Korean journal of pain.

[5]  S. Daniels,et al.  Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: a randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-center, , 2010, Clinical therapeutics.

[6]  P. Peloso,et al.  Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials : bridging a gap between clinical trials and clinical practice , 2009 .

[7]  F. Coluzzi,et al.  What anesthesiologists should know about paracetamol (acetaminophen). , 2009, Minerva anestesiologica.

[8]  R. Moore,et al.  Topical capsaicin for chronic neuropathic pain in adults. , 2009, The Cochrane database of systematic reviews.

[9]  K. Kroenke,et al.  Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. , 2009, General hospital psychiatry.

[10]  S. Alahuhta,et al.  Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial. , 2009, Clinical therapeutics.

[11]  Seena K. Ajit,et al.  The molecular basis of pain and its clinical implications in rheumatology , 2009, Nature Clinical Practice Rheumatology.

[12]  A. Sabato,et al.  Controlled-Release Oxycodone and Pregabalin in the Treatment of Neuropathic Pain: Results of a Multicenter Italian Study , 2008, European Neurology.

[13]  G. Jancsó,et al.  Activation of the transient receptor potential vanilloid‐1 (TRPV1) channel opens the gate for pain relief , 2008, British journal of pharmacology.

[14]  U. Singh,et al.  Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic cholecystectomy. , 2008, British journal of anaesthesia.

[15]  O. Mathiesen,et al.  Pregabalin and dexamethasone for postoperative pain control: a randomized controlled study in hip arthroplasty. , 2008, British journal of anaesthesia.

[16]  M. Mula.  Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. , 2008, Current drug metabolism.

[17]  J. Deleo,et al.  A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain , 2008, Brain Research.

[18]  F. López-Muñoz,et al.  Dopamine receptors in the anterior insular cortex modulate long‐term nociception in the rat , 2008, European journal of pain.

[19]  R. Raffa,et al.  Looking beyond the administered drug: metabolites of opioid analgesics. , 2008, The Journal of family practice.

[20]  Patrick Thiebaud,et al.  Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen , 2008, Vascular health and risk management.

[21]  N. Rawal,et al.  Intraarticular Administration of Ketorolac, Morphine, and Ropivacaine Combined with Intraarticular Patient-Controlled Regional Analgesia for Pain Relief After Shoulder Surgery: A Randomized, Double-Blind Study , 2008, Anesthesia and analgesia.

[22]  J. Farrar,et al.  Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.

[23]  Kirk W. Johnson,et al.  Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward , 2007, TheScientificWorldJournal.

[24]  S. Maier,et al.  “Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids , 2007, Brain Research Reviews.

[25]  M. Max,et al.  Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain , 2007, PAIN.

[26]  I. C. Tudor,et al.  Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. , 2007, Clinical therapeutics.

[27]  J. George,et al.  Predictors of refill non-adherence in patients with heart failure. , 2007, British journal of clinical pharmacology.

[28]  J. Eisenach,et al.  Gabapentin Activates Spinal Noradrenergic Activity in Rats and Humans and Reduces Hypersensitivity after Surgery , 2007, Anesthesiology.

[29]  E. Fauman,et al.  Pharmacology and mechanism of action of pregabalin: The calcium channel α2–δ (alpha2–delta) subunit as a target for antiepileptic drug discovery , 2007, Epilepsy Research.

[30]  P. Moore,et al.  Adverse drug interactions involving common prescription and over-the-counter analgesic agents. , 2007, Clinical therapeutics.

[31]  E. Fauman,et al.  Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. , 2007, Epilepsy research.

[32]  D. Wijeysundera,et al.  Use of gabapentin for perioperative pain control -- a meta-analysis. , 2007, Pain research & management.

[33]  J. Stinson,et al.  Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. , 2007, Pain research & management.

[34]  C. Taylor,et al.  Pregabalin action at a model synapse: Binding to presynaptic calcium channel α2-δ subunit reduces neurotransmission in mice , 2006 .

[35]  T. Nurmikko,et al.  EFNS guidelines on pharmacological treatment of neuropathic pain , 2006, European journal of neurology.

[36]  A. Eschalier,et al.  Antidepressants and pain. , 2006, Trends in pharmacological sciences.

[37]  R. Raffa,et al.  Pharmacological aspects of successful long-term analgesia , 2006, Clinical Rheumatology.

[38]  M. Versavel,et al.  Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial , 2006, Current medical research and opinion.

[39]  Robert W. Gereau,et al.  Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α , 2006, The Journal of Neuroscience.

[40]  C. Taylor,et al.  Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice. , 2006, European journal of pharmacology.

[41]  L. Lamoreaux,et al.  Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. , 2005, The journal of pain : official journal of the American Pain Society.

[42]  M. Tanabe,et al.  Role of descending noradrenergic system and spinal α2‐adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse , 2005, British journal of pharmacology.

[43]  C. Sachs.  Oral analgesics for acute nonspecific pain. , 2005, American family physician.

[44]  M. Maizels,et al.  Antidepressants and antiepileptic drugs for chronic non-cancer pain. , 2005, American family physician.

[45]  D. Selvarajah,et al.  Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.

[46]  R. Poole,et al.  Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.

[47]  Eija Kalso,et al.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety , 2004, Pain.

[48]  T. Schnitzer,et al.  A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. , 2004, Arthritis and rheumatism.

[49]  J. Rosenstock,et al.  Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.

[50]  J. Apfelbaum,et al.  Practice Guidelines for Acute Pain Management in the Perioperative Setting: An Updated Report by the American Society of Anesthesiologists Task Force on Acute Pain Management , 2004, Anesthesiology.

[51]  M. Versavel,et al.  Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial , 2004, Pain.

[52]  H. Skinner.  Multimodal acute pain management. , 2004, American journal of orthopedics.

[53]  Clifford J. Woolf,et al.  Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management , 2004, Annals of Internal Medicine.

[54]  S. Woolf.  Patient Safety Is Not Enough: Targeting Quality Improvements To Optimize the Health of the Population , 2004, Annals of Internal Medicine.

[55]  S. Koizumi,et al.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.

[56]  I. Hentall,et al.  Temporal and spatial profiles of pontine-evoked monoamine release in the rat's spinal cord. , 2003, Journal of neurophysiology.

[57]  Jörn Lötsch,et al.  Peripheral opioid analgesia in experimental human pain models. , 2003, Brain : a journal of neurology.

[58]  R. Poole,et al.  Pregabalin for the treatment of postherpetic neuralgia , 2003, Neurology.

[59]  M. Rowbotham,et al.  Oral opioid therapy for chronic peripheral and central neuropathic pain. , 2003, The New England journal of medicine.

[60]  P. Manfredi.  Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial , 2003, Neurology.

[61]  J. Micó,et al.  The Role of 5-HT1A/B Autoreceptors in the Antinociceptive Effect of Systemic Administration of Acetaminophen , 2003, Anesthesiology.

[62]  S. C. Armstrong,et al.  Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, Part II. , 2003, Psychosomatics.

[63]  C. Argoff.  Targeted topical peripheral analgesics in the management of pain , 2003, Current pain and headache reports.

[64]  R. Dubner,et al.  Attenuation of Pain in a Randomized Trial by Suppression of Peripheral Nociceptive Activity in the Immediate Postoperative Period , 2002, Anesthesia and analgesia.

[65]  C. Woolf,et al.  p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat Hyperalgesia , 2002, Neuron.

[66]  C. Inturrisi.  Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.

[67]  M. Ashburn,et al.  Adverse events associated with postoperative opioid analgesia: a systematic review. , 2002, The journal of pain : official journal of the American Pain Society.

[68]  M. Curatolo,et al.  Neuroplasticity--an important factor in acute and chronic pain. , 2002, Swiss medical weekly.

[69]  A. Basbaum,et al.  The 5-HT3 Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors , 2002, The Journal of Neuroscience.

[70]  F. Chung,et al.  Multimodal analgesia for postoperative pain control. , 2001, Journal of clinical anesthesia.

[71]  M. Lazdunski,et al.  Nonsteroid Anti-Inflammatory Drugs Inhibit Both the Activity and the Inflammation-Induced Expression of Acid-Sensing Ion Channels in Nociceptors , 2001, The Journal of Neuroscience.

[72]  T. McDowell,et al.  Local Anesthetic Inhibition of Voltage-activated Potassium Currents in Rat Dorsal Root Ganglion Neurons , 2001, Anesthesiology.

[73]  A. Gottschalk,et al.  New concepts in acute pain therapy: preemptive analgesia. , 2001, American family physician.

[74]  P. Wiffen,et al.  Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. , 2000, Journal of pain and symptom management.

[75]  R. Tallarida,et al.  Discovery of "self-synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol). , 2000, The Journal of pharmacology and experimental therapeutics.

[76]  C. Woolf,et al.  Pain: molecular mechanisms. , 2000, The journal of pain : official journal of the American Pain Society.

[77]  E. Skovlund,et al.  Combining diclofenac with acetaminophen or acetaminophen‐codeine after oral surgery: A randomized, double‐blind single‐dose study , 1999, Clinical pharmacology and therapeutics.

[78]  J. Rosenberg,et al.  Multi-regional local anesthetic infiltration during laparoscopic cholecystectomy in patients receiving prophylactic multi-modal analgesia: a randomized, double-blinded, placebo-controlled study. , 1999, Anesthesia and analgesia.

[79]  G. A. Wilkinson,et al.  Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  M. Rowbotham,et al.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study , 1999, Pain.

[81]  M. Rowbotham,et al.  Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. , 1998, JAMA.

[82]  C Peter N Watson,et al.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. , 1998, Neurology.

[83]  W Vogel,et al.  Complex blockade of TTX-resistant Na+ currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons. , 1998, Journal of neurophysiology.

[84]  H. Fields,et al.  Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons. , 1998, Journal of neurophysiology.

[85]  J. Meldolesi,et al.  HIV‐1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid , 1997, FEBS letters.

[86]  J. Eisenach,et al.  Alfentanil, but Not Amitriptyline, Reduces Pain, Hyperalgesia, and Allodynia from Intradermal Injection of Capsaicin in Humans , 1997, Anesthesiology.

[87]  W. S. Beattie,et al.  The Addition of Continuous Intravenous Infusion of Ketorolac to a Patient-Controlled Analgetic Morphine Regime Reduced Postoperative Myocardial Ischemia in Patients Undergoing Elective Total Hip or Knee Arthroplasty , 1997, Anesthesia and analgesia.

[88]  R. Dubner,et al.  Blockade of peripheral neuronal barrage reduces postoperative pain , 1997, Pain.

[89]  J. Vanneste,et al.  Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain , 1997, The Lancet.

[90]  A. Stubhaug,et al.  Longterm treatment of chronic neuropathic pain with the NMDA (N‐methyl‐D‐aspartate) receptor antagonist ketamine , 1997, Acta anaesthesiologica Scandinavica.

[91]  Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. , 1997, Anesthesiology.

[92]  H. J. McQuay,et al.  A systematic review of antidepressants in neuropathic pain , 1996, Pain.

[93]  M. Rowbotham,et al.  Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia , 1996, Pain.

[94]  K. Korttila,et al.  Balanced analgesia improves recovery and outcome after outpatient tubal ligation , 1996, Acta anaesthesiologica Scandinavica.

[95]  J. Merrill,et al.  Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain , 1995, The Journal of experimental medicine.

[96]  H. Ushijima,et al.  Exposure to gp120 of HIV‐1 Induces an Increased Release of Arachidonic Acid in Rat Primary Neuronal Cell Culture Followed by NMDA Receptor‐mediated Neurotoxicity , 1995, The European journal of neuroscience.

[97]  J. Levine,et al.  Temporal factors in the enhancement of morphine analgesia by desipramine , 1993, Pain.

[98]  R Dubner,et al.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.

[99]  P. Morley-Forster,et al.  Indomethacin as a postoperative analgesic for total hip arthroplasty , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[100]  S. Fleetwood-Walker,et al.  Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. , 1988, The Journal of physiology.

[101]  B. Meyerson,et al.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.

[102]  J. Levine,et al.  Desipramine enhances opiate postoperative analgesia , 1986, Pain.

[103]  M. Piercey,et al.  Morphine depresses dorsal horn neuron responses to controlled noxious and non-noxious cutaneous stimulation. , 1980, The Journal of pharmacology and experimental therapeutics.